Found 109 matching trials
Tongxinluo Improve High on Clopidogrel Platelet Reactivity Patients With Coronary Heart Disease PHASE4 Tongxinluo is a kind of Chinese patent drug,which could promote blood circu...
Show More Location
ShenZhou Hopital Of ShenYang Medical College
Learn More & Join Trial
Anti-Platelets in Chronic Obstructive Pulmonary Disease PHASE2 This is a 6 week crossover study in current and former smokers with and wit...
Show More Location
Brigham and Women's Hospital
Learn More & Join Trial
A Study to Investigate the Interaction Between ACT-246475 and Clopidogrel, Prasugrel, and Ticagrelor in Healthy Subjects PHASE1 The primary objective of this study is to assess the pharmacodynamic (PD) e...
Show More Learn More & Join Trial
Duration of Dual Anti-Platelet Therapy in Chronic Limb Threatening Ischemia After Distal Revascularization PHASE3 Chronic limb threatening ischemia (CLTI) is defined as ischemic foot pain a...
Show More Location
Hospital Saint Joseph
Learn More & Join Trial
DLBS1033 for Acute NSTEMI Without Early Coronary Revascularization PHASE2 This is a prospective, randomized, double-blind, double-dummy, and controll...
Show More Location
Central Army Hospital RSPAD Gatot Soebroto
Learn More & Join Trial
Efficacy Study of Cilostazol Loading in Elective Percutaneous Coronary Intervention PHASE4 The purpose of this study is to investigate the effect of cilostazol loadin...
Show More Location
Samsung Medical Center
Learn More & Join Trial
Investigation of the Athero-Protective Effects of Clopidogrel PHASE4 The investigators would like to investigate whether clopidogrel will help l...
Show More Location
Emory University Hospital
Learn More & Join Trial
Study on the Effectiveness and Safety of Shuxinin Injection in the Treatment of Acute Ischemic Stroke PHASE4 This is a randomized, double-blind, placebo-parallel-controlled multiplier ...
Show More Location
Peking University Third Hospital
Learn More & Join Trial
Trial in Subjects Undergoing Cardiac Catheterization With Planned Percutaneous Coronary Intervention With Stenting PHASE2 The purpose of this study is to provide information of the relative potency...
Show More Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Learn More & Join Trial
Effectiveness of Intensive Lipid Modification Medication in Preventing the Progression of Peripheral Arterial Disease (The ELIMIT Study) PHASE4 Peripheral arterial disease (PAD) occurs when arteries become narrowed or h...
Show More Location
Baylor College of Medicine
Learn More & Join Trial